Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5h credit for physicians, pharmacists, and nurses.
The Expanding Role of SGLT2i in CV Disease
1) Welcome to a Tweetorial on #SGLT2i & CV health. “Flozinators of the world, unite!” Accredited for 0.50h by @academiccme: #physicians,...
A Case-Based Review of the Most Current Data on Duration of DAPT at 1 Year After ACS/PCI
1) Welcome to our accredited tweetorial on the evidence basis for duration of #DAPT after #ACS/#PCI. This activity is intended for healthcare...
GLP-1 RAs, CV Outcomes, Obesity Mgt, & T2D
1) Welcome to a tweetorial on GLP-1 RAs, CV outcomes, obesity mgt, & T2D! Accredited for 0.50h by @academiccme: physicians, nurses, pharmacists!...
A Journal Club on a New Therapeutic Option to Reduce the Progression of Diabetic Kidney Disease: Finerenone – a Non-Steroidal Mineralocorticoid Receptor Antagonist
1) Welcome to a joint-accredited tweetorial on a new therapeutic option to reduce the progression of diabetic kidney disease: finerenone – a...
The Various Important Roles Hospital and Community Pharmacists Play in Optimizing Cardiometabolic Care
1) Welcome to a tweetorial on optimizing the role of the pharmacist in managing cardiometabolic disease! Accredited for 0.50 credits by...
The Use of P2Y12 Inhibitor Monotherapy After PCI
1) Welcome to a tweetorial on the use of P2Y12 inhibitor monotherapy after PCI! Accredited for 0.50 credits by @academiccme: physicians, nurses,...
A Case-Based Program on Evidence-Based Management of PAD
1) Welcome to our accredited tweetorial on #PAD ! Expert faculty @JoshuaBeckmanMD. Earn 0.5h CME/CE credit by following this thread. Supported by...
New Insulin Options For Patients With T1D
1) Welcome to a tweetorial on new insulin options for treating T1D! Accredited for 0.50 credits by @academiccme: physicians, nurses, pharmacists! I...
Hypertension Management in Aortic Dissection
1) Welcome to a tweetorial on #hypertension management in #AorticDissection! Accredited for 0.50 CE/CME credits by @academiccme: physicians, nurses,...
Using New-Generation K+ Binders to Treat Acute Hyperkalemia
2) . . . Supported by educational grant funding from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. Follow this thread for credit. And here is a...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.
Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.
Such an honor to speak at #pert21! @cardiomet_CE https://twitter.com/RosovskyRachel/status/1449449789574291456
@md_pollack creates a new term: BWI - bleeding while impaired @PERTConsortium #pert2021 @DebSiegal @CMichaelGibson @jameshorowitzmd @YevgeniyBr
Super-excited about this @cardiomet_CE accredited tweetorial: #antiplatelet Rx in STEMI w/ shock
🗓️See you tomorrow!
#Cardiotwitter #CardioEd
Good to be using #SoMe time productively🙈
@Ortega_Paz @mirvatalasnag @IndahSP_MD @iamritu @chadialraies @mmamas1973 @PCRonline https://twitter.com/cardiomet_CE/status/1449088036046786563
Don’t miss a new accredited #tweetorial launching Monday here on @cardiomet_ce. Our newest core faculty member, #interventionalist & #SoMe education enthusiast @aayshacader will be discussing #antiplatelet tx in an oh-so-tough scenario--#cardiogenicshock complicating #STEMI.
For those of you who missed it last week here are my updated @GPnotebook prescribing tools for prescribing in T2D & renal impairment and also extra-glycaemic indications of SGLT2 inhibitors
PDF download at https://gpnotebookeducation.com
All feedback welcome!
@nephondemand